An Open-Label, Rollover Platform Study for Continued Study Treatment and Ongoing Safety Monitoring

2024-515457-21-00 Protocol PLATFORMPACAN1001 Human pharmacology (Phase I) - Other Ongoing, recruiting

Start 30 Dec 2024 · Status Ongoing, recruiting · 5 EU/EEA countries · 20 sites · Protocol PLATFORMPACAN1001

Overview

Sponsor-declared trial summary

Phase Human pharmacology (Phase I) - Other
Status Ongoing, recruiting
Participants planned 117
Countries 5
Sites 20

Non-Hodgkin lymphoma and chronic lymphocytic leukemia

Key facts

Sponsor
Janssen Cilag International
Participant type
Patients
Age range
65+ years
Gender
Male and Female
Therapeutic area
Diseases [C] - Neoplasms [C04]
Trial duration
30 Dec 2024 → ongoing
Decision date (initial)
2024-12-18
Transition trial
No
Low-intervention
No
Rare-disease indication
No
Vulnerable population
Yes

Trial design

CTIS Part I — objectives, methods, condition coding

Conditions and MedDRA coding

Non-Hodgkin lymphoma and chronic lymphocytic leukemia

VersionLevelCodeTermSystem organ class
23.1 LLT 10084346 B-cell non-Hodgkin´s lymphoma 100000004848
21.0 LLT 10008976 Chronic lymphocytic leukemia 10029104

Sponsors and contacts

Sponsor organisations, regulatory contacts, third parties

Janssen Cilag International

Sponsor organisation
Janssen Cilag International
Address
Turnhoutseweg 30
City
Beerse
Postcode
2340
Country
Belgium

Scientific contact point

Organisation
Janssen Cilag International
Contact name
CTIS Point of Contact

Public contact point

Organisation
Janssen Cilag International
Contact name
CTIS Point of Contact

Locations

5 EU/EEA countries · 20 investigational sites

By country

CountryMS statusPlanned subjectsSites
Belgium Ongoing, recruiting 1 1
France Ongoing, recruiting 5 6
Greece Ongoing, recruiting 1 1
Poland Ongoing, recruiting 30 4
Spain Ongoing, recruiting 15 8
Rest of world
Australia, Georgia, Israel, United States, Japan, Moldova, Republic of, Korea, Republic of, Taiwan, Ukraine, United Kingdom
65

Investigational sites

Belgium

1 site · Ongoing, recruiting
Universitair Ziekenhuis Gent
Hematology, Corneel Heymanslaan 10, 9000, Gent

France

6 sites · Ongoing, recruiting
Centre Hospitalier Universitaire De Lille
Hopital Claude Huriez - Service des Maladies du sang, Rue Michel Polonowski, 59000, Lille
Institut Paoli Calmettes
Hematology Department, 232 Boulevard De Sainte Marguerite, Bp 156, Marseille
Centre Hospitalier Universitaire De Nantes
Clinical Hematology, 1 Place Alexis Ricordeau, 44000, Nantes
Institut Gustave Roussy
Département d’Innovations Thérapeutiques et d’essais Précoces (DITEP), 114 Rue Edouard Vaillant, 94800, Villejuif
Institut Curie
Unité d’Investigation Clinique Adulte, 26 Rue D Ulm, 75005, Paris
Oncopole Claudius Regaud
Institut Universitaire du Cancer I.U.C.Toulouse – Oncopôle Département Hématologie, 1 Avenue Irene Joliot Curie, 31100, Toulouse

Greece

1 site · Ongoing, recruiting
General Hospital Of Athens Alexandra
Department of Clinical Therapeutics, Vassilissis Sofias Avenue 80, 115 28, Athens

Poland

4 sites · Ongoing, recruiting
Pratia S.A.
Pratia MCM, Ul. Pana Tadeusza 2, 30-727, Cracow
Pratia Hematologia Sp. z o.o.
Pratia Onkologia Katowice, Ul. Tadeusza Kosciuszki 92, 40-519, Katowice
Uniwersyteckie Centrum Kliniczne
Osrodek Badan Klinicznych Wczesnych Faz, Ul. Mariana Smoluchowskiego 17, 80-214, Gdansk
Aidport Sp. z o.o.
Aidport Sp z o o, Ul Ksiedza Stanisława Kozierowskiego 24, 60-185, Skorzewo

Spain

8 sites · Ongoing, recruiting
Clinica Universidad De Navarra
Hematology Department, Pio XII Etorbidea 36, 31008, Pamplona
Clinica Universidad De Navarra
Hematology Department, Pio XII Etorbidea 36, 31008, Pamplona
Hospital Clinic De Barcelona
Hematology Department, Calle Villarroel 170, 08036, Barcelona
Hospital Universitario 12 De Octubre
Hematology Department, Avenida De Cordoba Sn, 28041, Madrid
Hospital Universitario De Salamanca
Hematology Department, Paseo De San Vicente 58-182, 37007, Salamanca
Hospital Universitari Vall D Hebron
Oncology department, Passeig De La Vall D'Hebron 119-129, 08035, Barcelona
Hospital Universitario Fundacion Jimenez Diaz
Oncology department, Avenida De Los Reyes Catolicos 2, 28040, Madrid
Hospital Universitari Vall D Hebron
Hematology Department, Passeig De La Vall D'Hebron 119-129, 08035, Barcelona

Country notifications

Trial-start, recruitment-start, end and early-termination notifications submitted per Member State

Country Trial startTrial end Recruitment startRecruitment end Early termination
Belgium 2025-01-13 2025-01-13
France 2025-02-06 2025-02-06
Greece 2025-02-27 2025-02-27
Poland 2024-12-30 2024-12-30
Spain 2025-08-25 2025-08-25

Application history

8 submissions — initial application plus substantial / non-substantial modifications

#TypeCodeSubmittedReference MSConclusionDecision date
1 INITIAL IN 2024-08-27 France Acceptable
2024-12-16
2024-12-16
2 SUBSTANTIAL MODIFICATION SM-1 2025-01-24 France Acceptable
2025-04-04
2025-04-07
3 SUBSEQUENT ADDITION OF MSC APP-3 2025-04-30 2025-06-20
4 NON SUBSTANTIAL MODIFICATION NSM-1 2025-10-01 France 2025-10-01
5 NON SUBSTANTIAL MODIFICATION NSM-2 2025-10-01 France 2025-10-01
6 NON SUBSTANTIAL MODIFICATION NSM-3 2025-12-05 France 2025-12-05
7 SUBSTANTIAL MODIFICATION SM-3 2026-01-27 France Acceptable
2026-04-10
2026-04-13
8 NON SUBSTANTIAL MODIFICATION NSM-4 2026-04-22 France Acceptable
2026-04-10
2026-04-22